Robert Schulingkamp

890 total citations
14 papers, 606 citations indexed

About

Robert Schulingkamp is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Robert Schulingkamp has authored 14 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Robert Schulingkamp's work include CAR-T cell therapy research (2 papers), Animal testing and alternatives (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Robert Schulingkamp is often cited by papers focused on CAR-T cell therapy research (2 papers), Animal testing and alternatives (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). Robert Schulingkamp collaborates with scholars based in United States and Belgium. Robert Schulingkamp's co-authors include Robert B. Raffa, Tiziana Pagano, Dong‐Zong Hung, Joseph M. Valdez, Robert B. Raffa, Shawn D. Spencer, Ronald J. Tallarida, Vincent J. Aloyo, Kathryn Packman and Qun Jiao and has published in prestigious journals such as Cancer Research, Neuroscience & Biobehavioral Reviews and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Robert Schulingkamp

13 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Schulingkamp United States	9	235	157	151	91	78	14	606
Béatrice Georges France	14	243 1.0×	143 0.9×	83 0.5×	66 0.7×	36 0.5×	26	711
Cédric S. Asensio United States	14	377 1.6×	247 1.6×	214 1.4×	116 1.3×	131 1.7×	22	876
Maik Grohmann Germany	11	381 1.6×	157 1.0×	240 1.6×	42 0.5×	72 0.9×	14	1.0k
Hayato Matsunaga Japan	17	404 1.7×	137 0.9×	141 0.9×	64 0.7×	26 0.3×	48	772
Sivan Vadakkadath Meethal United States	18	354 1.5×	192 1.2×	126 0.8×	46 0.5×	134 1.7×	26	1.1k
Takayuki Negishi Japan	18	233 1.0×	114 0.7×	186 1.2×	39 0.4×	177 2.3×	55	1.0k
G. Stefano Brigidi Canada	11	442 1.9×	245 1.6×	255 1.7×	89 1.0×	117 1.5×	11	940
Qi Xi China	15	412 1.8×	129 0.8×	121 0.8×	114 1.3×	39 0.5×	50	671
Patricia A. Glazebrook United States	15	349 1.5×	175 1.1×	248 1.6×	131 1.4×	60 0.8×	24	783
Steven C. Wyler United States	11	257 1.1×	128 0.8×	171 1.1×	118 1.3×	64 0.8×	18	633

Countries citing papers authored by Robert Schulingkamp

Since Specialization

Citations

This map shows the geographic impact of Robert Schulingkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schulingkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schulingkamp more than expected).

Fields of papers citing papers by Robert Schulingkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Schulingkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schulingkamp. The network helps show where Robert Schulingkamp may publish in the future.

Co-authorship network of co-authors of Robert Schulingkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Schulingkamp. A scholar is included among the top collaborators of Robert Schulingkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Schulingkamp. Robert Schulingkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Excoffon, Katherine J. D. A., Mark Bodman‐Smith, Robert Schulingkamp, et al.. (2024). Inhalation of SP-101 Followed by Inhaled Doxorubicin Results in Robust and Durable hCFTRΔR Transgene Expression in the Airways of Wild-Type and Cystic Fibrosis Ferrets. Human Gene Therapy. 35(17-18). 710–725. 5 indexed citations

Gaffney, Dana, Eileen Vesely, David Pocalyko, et al.. (2022). Abstract 1416: Aurora kinase is synthetic lethal with APC loss of function in engineered human colon organoid models. Cancer Research. 82(12_Supplement). 1416–1416.

Diem, Michael, Weirong Wang, Robert Schulingkamp, et al.. (2020). Abstract 5662: JNJ-67571244: A novel anti-CD33 C2 domain binding bispecific antibody with potent T cell redirection activity. Cancer Research. 80(16_Supplement). 5662–5662. 1 indexed citations

Diem, Michael, Weirong Wang, Robert Schulingkamp, et al.. (2020). A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia. Blood Advances. 4(5). 906–919. 35 indexed citations

Maguire, Sean, et al.. (2019). An IQ Consortium Perspective on The Scientific Committee on Health, Environmental and Emerging Risks Final Opinion on the Need for Nonhuman Primates in Biomedical Research, Production and Testing of Products and Devices (Update 2017). Toxicologic Pathology. 47(5). 649–655. 13 indexed citations

Morgan, Sherry J., Jessica A. Couch, Peggy Guzzie‐Peck, et al.. (2017). Regulatory Forum Opinion Piece^*: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry Survey. Toxicologic Pathology. 45(3). 372–380. 9 indexed citations

Schulingkamp, Robert, Raymond W. Colburn, Dennis J. Stone, et al.. (2007). Urotensin‐II Induces Ear Flushing in Rats. British Journal of Pharmacology. 150(4). 415–423. 8 indexed citations

Schulingkamp, Robert, Vincent J. Aloyo, Ronald J. Tallarida, & Robert B. Raffa. (2005). Changes in Aorta Alpha<sub>1</sub>-Adrenoceptor Number and Affinity during One Year of Streptozotocin-Induced Diabetes in Rats. Pharmacology. 74(1). 23–30. 12 indexed citations

Spencer, Shawn D., et al.. (2002). Toward the Design of Ribonuclease (RNase) Inhibitors: Ion Effects on the Thermodynamics of Binding of 2′-CMP to RNase A. Journal of Pharmacology and Experimental Therapeutics. 301(3). 925–929. 8 indexed citations

10.

Schulingkamp, Robert, et al.. (2002). Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids. Journal of Clinical Pharmacy and Therapeutics. 27(3). 161–168. 23 indexed citations

11.

Raffa, Robert B., Shawn D. Spencer, & Robert Schulingkamp. (2002). Toward RNase inhibitors: thermodynamics of 2′-CMP/RNase-A binding in multi-ion buffer. Biochemical Pharmacology. 63(11). 1937–1939. 6 indexed citations

12.

Raffa, Robert B., et al.. (2001). Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. Journal of Pharmacological and Toxicological Methods. 45(3). 223–226. 81 indexed citations

13.

Raffa, Robert B., et al.. (2000). Energy-dependent UV light-induced disruption of (−)sulpiride antagonism of dopamine. European Journal of Pharmacology. 406(3). R11–R12. 22 indexed citations

14.

Schulingkamp, Robert, Tiziana Pagano, Dong‐Zong Hung, & Robert B. Raffa. (2000). Insulin receptors and insulin action in the brain: review and clinical implications. Neuroscience & Biobehavioral Reviews. 24(8). 855–872. 383 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact